Circulation-heart Failure

Journal Title：Circulation-heart Failure

Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.

《循環(huán)：心力衰竭》雜志考慮發(fā)表與心力衰竭、機械循環(huán)支持和心臟移植科學和醫(yī)學相關的內(nèi)容，包括對人類進行的研究或?qū)θ祟悢?shù)據(jù)的分析，以及具有直接臨床相關性或相關性的臨床前研究。作為一本主要針對臨床的雜志，最終發(fā)表的基礎研究和臨床前研究很少。那些將被考慮的研究都是新穎的，并且對心力衰竭領域有重大而直接的推動作用。編輯們對與心力衰竭直接相關的基礎科學研究特別感興趣，這些研究信息量大，可轉(zhuǎn)化為人類疾病，并在脊椎動物模型中進行。提交的文章中，只有不到 15% 最終得以發(fā)表。不直接涉及心力衰竭或心力衰竭治療的研究將不予考慮，包括在沒有心力衰竭底物的情況下研究心肌梗死、再灌注損傷或心律失常的機制。

Circulation-heart Failure創(chuàng)刊于2008年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵蓋醫(yī)學 - 心血管系統(tǒng)全領域，在行業(yè)領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)7.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。